Kurt Marhardt
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Expert Opinion on Age-Related Sex Hormone Changes and Hypogonadism in People With Multiple Sclerosis: A Delphi Consensus Program.
Journal: Neurology. Clinical practice
Published: March 07, 2025
Family planning and contraception in people with multiple sclerosis: perspectives for obstetricians, gynaecologists, and other health care professionals involved in reproductive planning.
Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Published: December 16, 2024
Assessing the duration of EDSS improvement after a therapy start: A novel approach applied to the long-term extension of the PRISMS study.
Journal: Multiple sclerosis and related disorders
Published: June 08, 2023
Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a US Claims Database.
Journal: Frontiers in neurology
Published: March 05, 2021
MAGNIMS score predicts long-term clinical disease activity-free status and confirmed disability progression in patients treated with subcutaneous interferon beta-1a.
Journal: Multiple sclerosis and related disorders
Published: June 26, 2020
No evidence of disease activity status in patients treated with early vs. delayed subcutaneous interferon β-1a.
Journal: Multiple sclerosis and related disorders
Published: August 09, 2019
Subcutaneous interferon β-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: September 02, 2016
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.
Journal: European journal of neurology
Published: August 14, 2015
Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study.
Journal: Expert opinion on drug delivery
Published: June 23, 2015
The STAR Study: a real-world, international, observational study of the safety and tolerability of, and adherence to, serum-free subcutaneous interferon β-1a in patients with relapsing multiple sclerosis.
Journal: Clinical therapeutics
Published: October 22, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026